Financial updates
Pharming announces issue of shares as majority of remaining warrants are exercised
Pharming Group N.V. today announced that during the period of 7 to 9 March, it has issued a total of 6,315,235 new shares following the exercise of warrants representing a total of 9,174,372 shares.
“These exercises of warrants remove almost the entire overhang on the share represented by these instruments that were necessary to obtain the financing to re-acquire the North American rights for RUCONEST®”
- Sijmen de Vries - CEO